Sanofi Ventures has led a $17m investment in Click Therapeutics, which develops software to treat medical conditions such as depression, insomnia, acute coronary syndrome and chronic pain, via a mobile app prescribed by doctors. The latest example: Click Therapeutics announced Monday that it grabbed a $17 million investment led by Sanofi Ventures, the Cambridge, MA-based venture capital arm of the French pharmaceutical giant. Click is seeking clearance from the US Food and Drug Administration (FDA) to sell the products as class 2 medical devices. The company says it will use its new funding to develop an “innovative platform for delivering personalized medicine based on patient data that can be used across multiple healthcare systems”.
Sanofi Ventures has led a $17m investment in Click Therapeutics, which develops software to treat medical conditions such as depression, insomnia, acute coronary syndrome and chronic pain, via a mobile app prescribed by doctors. Click is seeking clearance from the US Food and Drug Administration (FDA) to sell the products as class 2 medical devices. The company says it will use its new funding to develop an “innovative platform for delivering personalized medicine based on patient data that can be used across multiple healthcare systems”.